No - not kidding. My reference to Milk's post was my assumption that because the abstract was published and distributed, there would have been an ASX announcement if it had been 'pulled'.
On re-reading the announcement, I now think that because the more detailed outcomes of the study are 'in press' with the Stroke Journal, they are still confidential and that the presentations by Davis and dos Santos would not have extended beyond what was included in the Abstract and the ASX Announcement.
We will just have to wait for the next edition of Stroke.x
Ann: Latest Imaging and Clinical Trial Insights, page-42
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.92 |
Change
-0.045(2.29%) |
Mkt cap ! $164.0M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.01 | $1.92 | $60.46K | 30.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | $1.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 588 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |